- Combination niacin and statin therapy in primary and secondary prevention of cardiovascular diseaseDeborah R Levy
University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
Clin Cardiol 28:317-20. 2005..2 mmol/I (< 200 mg/dl). Combination therapy offers a means to get more people to goal. This paper reviews the impact of lipid-modifying combination therapy with niacin plus a statin on lipid profile outcomes...
- Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" CommentaryDeborah R Levy
Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, New York, USA
J Gerontol A Biol Sci Med Sci 60:597-8; author reply 602. 2005